A composition suitable for hot melt extrusion to form thin strips containing active pharmaceutical ingredients is provided. The composition has 10 to 75% by weight of polyethylene oxide having a molecular weight of from 70,000 to 230,000 Daltons； 5 to 35% of a sugar alcohol having a melting point in excess of 75° C.； 5 to 20% by weight of polyethylene glycol having a molecular weight of from 100 to 4,000 Daltons； and 10 to 75% by weight of coated active pharmaceutical ingredient (API).
